ES2128572T3 - Utilizacion de los derivados de cefem como agentes antimetastaticos. - Google Patents
Utilizacion de los derivados de cefem como agentes antimetastaticos.Info
- Publication number
- ES2128572T3 ES2128572T3 ES94921624T ES94921624T ES2128572T3 ES 2128572 T3 ES2128572 T3 ES 2128572T3 ES 94921624 T ES94921624 T ES 94921624T ES 94921624 T ES94921624 T ES 94921624T ES 2128572 T3 ES2128572 T3 ES 2128572T3
- Authority
- ES
- Spain
- Prior art keywords
- pct
- defined above
- organic radical
- sec
- organic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE AL USO DE DERIVADOS CONOCIDOS DE CEFEM DE LA FORMULA (I), EN LA QUE N ES CERO, UNO O DOS; R{SUP,1} ES HIDROGENO O UN RADICAL ORGANICO, R{SUP,2} REPRESENTA HALO O UN RADICAL ORGANICO O R{SUP,1} Y R{SUP,2} JUNTOS Y CON EL ATOMO DE CARBONO C-2 DEL NUCLEO DE CEFEM CONSTITUYEN UN GRUPO CARBOCICLICO O HETEROCICLICO; R{SUP,3} REPRESENTA R{SUP,2} SEGUN SE HA DEFINIDO ARRIBA O UN RADICAL ORGANICO, R{SUP,4} ES BIEN R{SUP,1} O UN GRUPO ORGANICO, R{SUP,5} ES BIEN R{SUP,1} COMO SE HA DEFINIDO ARRIBA O HALO O ALCOXI C{SUB,1}-C{SUB,6}, ALQUILTIO C{SUB,1}-C{SUB,6} O ACILAMINO C{SUB,1}-C{SUB,6}; R{SUP,6} ES R{SUP,2} COMO SE HA DEFINIDO ARRIBA O UN GRUPO ORGANICO, O UNA SAL FARMACEUTICAMENTE ACEPTABLE DE LOS MISMOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939314562A GB9314562D0 (en) | 1993-07-14 | 1993-07-14 | Use of cephem derivatives as anti-metastatic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2128572T3 true ES2128572T3 (es) | 1999-05-16 |
Family
ID=10738806
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES94921624T Expired - Lifetime ES2128572T3 (es) | 1993-07-14 | 1994-06-24 | Utilizacion de los derivados de cefem como agentes antimetastaticos. |
Country Status (15)
Country | Link |
---|---|
US (1) | US5777104A (es) |
EP (1) | EP0708779B1 (es) |
JP (1) | JPH09500118A (es) |
KR (1) | KR960703599A (es) |
AT (1) | ATE176235T1 (es) |
AU (1) | AU680526B2 (es) |
CA (1) | CA2167194A1 (es) |
DE (1) | DE69416311T2 (es) |
ES (1) | ES2128572T3 (es) |
GB (1) | GB9314562D0 (es) |
HU (1) | HUT72739A (es) |
IL (1) | IL110273A0 (es) |
PL (1) | PL312582A1 (es) |
WO (1) | WO1995002603A2 (es) |
ZA (1) | ZA945093B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9513818D0 (en) * | 1995-07-06 | 1995-09-06 | Pharmacia Spa | 7,7-Disubstituted cephem-4-ketones |
WO1997008174A1 (en) * | 1995-08-31 | 1997-03-06 | Smithkline Beecham Corporation | Interleukin converting enzyme and apoptosis |
JPH11514345A (ja) * | 1995-08-31 | 1999-12-07 | スミスクライン・ビーチャム・コーポレイション | インターロイキン変換酵素およびアポプトーシス |
US6858598B1 (en) | 1998-12-23 | 2005-02-22 | G. D. Searle & Co. | Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
US6833373B1 (en) | 1998-12-23 | 2004-12-21 | G.D. Searle & Co. | Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
EP2926815A1 (en) * | 2014-04-03 | 2015-10-07 | Institut Curie | New derivatives of cephalosporin for treating cancer |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0383987A (ja) * | 1989-08-26 | 1991-04-09 | Fujisawa Pharmaceut Co Ltd | 新規セフェム化合物およびその塩類 |
AU649275B2 (en) * | 1990-11-06 | 1994-05-19 | Bristol-Myers Squibb Company | Prodrugs for beta-lactamase and uses thereof |
GB2266525A (en) * | 1992-03-17 | 1993-11-03 | Merck & Co Inc | Substituted cephalosporin sulfone compositions useful in the treatment of leukemia |
-
1993
- 1993-07-14 GB GB939314562A patent/GB9314562D0/en active Pending
-
1994
- 1994-06-24 EP EP94921624A patent/EP0708779B1/en not_active Expired - Lifetime
- 1994-06-24 JP JP7504312A patent/JPH09500118A/ja not_active Ceased
- 1994-06-24 AU AU72277/94A patent/AU680526B2/en not_active Ceased
- 1994-06-24 CA CA002167194A patent/CA2167194A1/en not_active Abandoned
- 1994-06-24 KR KR1019960700153A patent/KR960703599A/ko not_active Application Discontinuation
- 1994-06-24 US US08/392,744 patent/US5777104A/en not_active Expired - Fee Related
- 1994-06-24 PL PL94312582A patent/PL312582A1/xx unknown
- 1994-06-24 HU HU9503852A patent/HUT72739A/hu unknown
- 1994-06-24 WO PCT/EP1994/002059 patent/WO1995002603A2/en active IP Right Grant
- 1994-06-24 ES ES94921624T patent/ES2128572T3/es not_active Expired - Lifetime
- 1994-06-24 DE DE69416311T patent/DE69416311T2/de not_active Expired - Fee Related
- 1994-06-24 AT AT94921624T patent/ATE176235T1/de not_active IP Right Cessation
- 1994-07-11 IL IL11027394A patent/IL110273A0/xx unknown
- 1994-07-13 ZA ZA945093A patent/ZA945093B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
ATE176235T1 (de) | 1999-02-15 |
DE69416311T2 (de) | 1999-08-26 |
HUT72739A (en) | 1996-05-28 |
GB9314562D0 (en) | 1993-08-25 |
EP0708779B1 (en) | 1999-01-27 |
PL312582A1 (en) | 1996-04-29 |
DE69416311D1 (de) | 1999-03-11 |
AU7227794A (en) | 1995-02-13 |
HU9503852D0 (en) | 1996-02-28 |
WO1995002603A2 (en) | 1995-01-26 |
JPH09500118A (ja) | 1997-01-07 |
EP0708779A1 (en) | 1996-05-01 |
KR960703599A (ko) | 1996-08-31 |
CA2167194A1 (en) | 1995-01-26 |
ZA945093B (en) | 1995-02-22 |
AU680526B2 (en) | 1997-07-31 |
IL110273A0 (en) | 1994-10-21 |
WO1995002603A3 (en) | 1995-03-09 |
US5777104A (en) | 1998-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ511394A (en) | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity | |
DE69327541D1 (en) | 4-arylmethyloxymethyl piperidine als tachykinin antagonisten | |
AR004493A1 (es) | Derivados de oxindol 3- sustituido util como moduladores de canales de potasio y composiciones farmaceuticas que lo contienen. | |
NO166129C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-9h-pyrido (3,4-b)indoler. | |
DK0677046T3 (da) | Piperazinderivater som 5-HT-antagonister. | |
ATE73790T1 (de) | Amino 5,6,7,8tetrahydronaphtho(2,3b>furanderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. | |
ES2098023T3 (es) | Compuestos de estructura guanidinica y composiciones farmaceuticas que los contienen. | |
FI945581A (fi) | Substituoidut (aryylialkoksibentsyyli) aminopropaaniamidijohdannaiset, niiden valmistus ja käyttö antiepileptisinä, neuroprotektiivisina ja antidepressiivisinä aineina | |
ES2128572T3 (es) | Utilizacion de los derivados de cefem como agentes antimetastaticos. | |
ES2138623T3 (es) | Derivados de pleuromutilina. | |
MX9301112A (es) | Derivados de indol. | |
ES2102327A1 (es) | Nuevos derivados de 2,2,6,6-tetrametilpiperidina para utilizarse como agentes estabilizantes para materiales organicos contra la luz, el calor, y la oxidacion. n | |
DE59304311D1 (de) | N-substituierte 3-azabicyclo[3.2.0]heptan-derivate als neuroleptika | |
ES2069313T3 (es) | Utilizacion de derivados de tiazoloisoindolinona como medicamentos antiviricos. | |
AU5674894A (en) | Azanoradamantanes | |
ES8304973A1 (es) | Un procedimiento para la preparacion de nuevos derivados de tiocarbapenem 3-sustituidos. | |
FI954218A0 (fi) | Bentsopyraaneja kaliumkanavan avaajina | |
YU200791A (sh) | Trifluorometil 1-karba (1-detia) cefemi | |
ATE148462T1 (de) | Isoxazole derivate als lichtschutzmittel | |
ATE169907T1 (de) | Azaspiroalkan-derivate als therapeutika |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 708779 Country of ref document: ES |